BIOMAT Database Logo BIOMAT Database Logo

Ischemia-reperfusion injury in a diet-induced rat fatty liver. 1998

B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Department of Discipline Chirurgiche, Rianimatorie e dei Trapianti, Bologna, Italy.

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D002796 Choline Deficiency A condition produced by a deficiency of CHOLINE in animals. Choline is known as a lipotropic agent because it has been shown to promote the transport of excess fat from the liver under certain conditions in laboratory animals. Combined deficiency of choline (included in the B vitamin complex) and all other methyl group donors causes liver cirrhosis in some animals. Unlike compounds normally considered as vitamins, choline does not serve as a cofactor in enzymatic reactions. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984) Deficiency, Choline,Choline Deficiencies,Deficiencies, Choline
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Warm ischemia and reperfusion injury in diet-induced canine fatty livers.
May 2000, Transplantation,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Hydrolyzed whey peptide-based diet ameliorates hepatic ischemia-reperfusion injury in the rat nonalcoholic fatty liver.
December 2014, Surgery today,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Rosiglitazone-enriched diet did not protect liver ischemia-reperfusion injury in a rat model.
January 2008, Acta cirurgica brasileira,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Misoprostol hepatoprotection against ischemia-reperfusion-induced liver injury in the rat.
August 1992, Digestive diseases and sciences,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Rivastigmine prevents injury induced by ischemia and reperfusion in rat liver.
September 2018, Acta cirurgica brasileira,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model.
January 2012, Biochemical and biophysical research communications,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Pharmacological postconditioning with diazoxide attenuates ischemia/reperfusion-induced injury in rat liver.
April 2013, Experimental and therapeutic medicine,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
PPARĪ± Agonist WY-14643 Induces SIRT1 Activity in Rat Fatty Liver Ischemia-Reperfusion Injury.
January 2015, BioMed research international,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Hepatic regeneration and ischemia/reperfusion injury in fatty-liver rats.
November 2000, Transplantation proceedings,
B Nardo, and M Domenicali, and P Caraceni, and P Turi, and M Dall'Agata, and A Mazziotti, and M Bernardi, and A Cavallari
Leptin attenuates ischemia-reperfusion injury in the rat liver.
December 2012, Transplant international : official journal of the European Society for Organ Transplantation,
Copied contents to your clipboard!